PREPARATION AND EVALUATION OF A TIME-CONTROLLED RELEASE CAPSULE MADE OF ETHYLCELLULOSE FOR COLON DELIVERY OF DRUGS

被引:68
作者
NIWA, K [1 ]
TAKAYA, T [1 ]
MORIMOTO, T [1 ]
TAKADA, K [1 ]
机构
[1] KYOTO PHARMACEUT UNIV,DEPT PHARMACEUT & PHAMACOKINET,YAMASHINA KU,KYOTO 607,JAPAN
关键词
ETHYLCELLULOSE; CAPSULE; TIME-CONTROLLED RELEASE; SWELLABLE SUBSTANCE; RELEASE TIME; COLON DELIVERY;
D O I
10.3109/10611869509059209
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A novel ethylcellulose (EC) capsule which releases drug with a time-controlled fashion has been prepared. This capsule is composed of four parts, drug container, swellable substance, capsule body and cap. At the bottom of the body, micropores are made. As water penetrates through these micropores, the swellable substance such as low substituted hydroxypropyl cellulose (L-HPC) swells. When the cap made of water-insoluble macromolecular substance such as EC cannot persist the swelling pressure, the EC cap disintegrates and the drug in the container is released from the capsule. The lag-time is utilized for the delivery of drug to the colon. The release time of the drug from the capsule was measured both in vitro and in vivo experiments. In the case of an in vitro experiment, after 12mg of fluorescein as a model drug and 238mg of starch were filled into the container, caps having different thickness were attached to the capsule body and release study was performed. The release time of the drug was mainly dependent on the thickness of the cap. Using test capsules of which mean cap thickness were 39.1 +/- 2.3 (SE)mu m, 63.1 +/- 5.0 mu m and 75.6 +/- 4.1 mu m, the in vivo release time was estimated after administration to beagle dogs. As a parameter, the peak time (t(max)) when plasma fluorescein concentration reached to its maximum level was determined for the estimation of the release time of the drug from the capsule in the gastrointestinal tract. The in vivo t(max) was well correlated with the cap thickness. These results show the possibility of new EC capsule for the colon delivery of drugs.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 35 条
[1]  
Andersen AC., 1970, BEAGLE EXPT DOG, P226
[2]   AN INVITRO INVESTIGATION INTO THE SUITABILITY OF PH-DEPENDENT POLYMERS FOR COLONIC TARGETING [J].
ASHFORD, M ;
FELL, JT ;
ATTWOOD, D ;
WOODHEAD, PJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 91 (2-3) :241-245
[3]  
ASHFORD M, 1993, CURRENT STATUS TARGE, P133
[4]   FORMULATION CONCERNS OF PROTEIN DRUGS [J].
CHEN, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (11-12) :1311-1354
[5]   CITRIC-ACID AS AN ADJUVANT FOR TRANS-EPITHELIAL TRANSPORT [J].
CHO, MJ ;
SCIESZKA, JF ;
BURTON, PS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 52 (01) :79-81
[6]  
COHEN AM, 1987, P NATL ACAD SCI USA, V84, P2284
[7]  
EGUCHI K, 1989, CANCER RES, V49, P5221
[8]   COLON-SPECIFIC DRUG DELIVERY [J].
FRIEND, DR .
ADVANCED DRUG DELIVERY REVIEWS, 1991, 7 (01) :149-199
[9]  
FRIEND DR, 1992, ORAL COLON SPECIFIC
[10]   ORAL VACCINES - DESIGN AND DELIVERY [J].
GILLIGAN, CA ;
PO, ALW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 75 (01) :1-24